Analytical Data
-
基因名
TPD52L2
- Application
-
别名
2810411G23Rik; AU016537; C86069; D54; DKFZp686A1765; HCCR binding Protein 2; hD54; MGC73020; RP23 33L3.2; TPD52L2; TPD54; TPD54_HUMAN; tumor Protein D52 like 2; Tumor Protein D52-like 2; Tumor Protein D54
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
O43399
-
表达区间
1-206 aa
-
氨基酸序列
MDSAGQDINL NSPNKGLLSD SMTDVPVDTG VAARTPAVEG LTEAEEEELR AELTKVEEEI VTLRQVLAAK ERHCGELKRR LGLSTLGELK QNLSRSWHDV QVSSAYVKTS EKLGEWNEKV TQSDLYKKTQ ETLSQAGQKT SAALSTVGSA ISRKLGDMRN SATFKSFEDR VGTIKSKVVG DRENGSDNLP SSAGSGDKPL SDPAPF
-
分子量
22.2 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
TPD52L2 (Tumor Protein D52-Like 2) is a member of the TPD52 family, which is implicated in cancer biology and cellular signaling processes. The protein is associated with diverse cellular functions, including cell proliferation, differentiation, and apoptosis, making it a potential biomarker for various types of cancers. Research has shown that TPD52L2 may play a critical role in tumorigenesis, potentially influencing cancer cell growth and metastasis through its interactions with other signaling molecules. The overexpression of TPD52L2 has been observed in several malignancies, indicating its potential role as an oncogene. As a result, the study of TPD52L2, particularly its recombinant protein form, aims to elucidate its biological functions and mechanisms of action within the cell. By producing and characterizing TPD52L2 recombinant protein, researchers strive to gain insights into its structure-function relationship, thus fostering the development of targeted therapies that may disrupt its oncogenic activities. Understanding TPD52L2's role in cancer could ultimately contribute to novel diagnostic tools and therapeutics, enhancing the prognosis and treatment strategies for patients with malignancies. The exploration of TPD52L2 continues to be a promising avenue in the field of cancer research, with implications for understanding tumor biology and improving patient outcomes.
